Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Miedema

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|January 1, 1997
Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive personsB M Brinkman, I P Keet, F Miedema, et al.
AIDS Research and Human Retroviruses|September 1, 1992
Differential tropism of clinical HIV-1 isolates for primary monocytes and promonocytic cell linesH Schuitemaker, N A Kootstra, M Groenink, et al.
Vox Sanguinis|January 1, 1987
Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testingJ G Huisman, I N Winkel, P N Lelie, et al.
The Journal of Clinical Investigation|April 1, 1997
Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphomaM J Kersten, M R Klein, A M Holwerda, et al.
European Journal of Immunology|June 1, 1984
Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity)F Miedema, P A Tetteroo, W G Hesselink, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Normal telomere lengths in naive and memory CD4+ T cells in HIV type 1 infection: a mathematical interpretationK C Wolthers, A J Noest, S A Otto, et al.
Drug and Alcohol Dependence|April 27, 1999
New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug usersA Krol, C Flynn, D Vlahov, et al.
Clinical and Experimental Immunology|February 1, 1986
An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subsetV E Moss, F Miedema, E Matutes, et al.
Clinical and Experimental Immunology|August 1, 1985
T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneousF Miedema, F G Terpstra, J W Smit, et al.
Blood|October 15, 1990
Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudineH Schuitemaker, N A Kootstra, M H van Oers, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|January 1, 1997
Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive personsB M Brinkman, I P Keet, F Miedema, et al.
AIDS Research and Human Retroviruses|September 1, 1992
Differential tropism of clinical HIV-1 isolates for primary monocytes and promonocytic cell linesH Schuitemaker, N A Kootstra, M Groenink, et al.
Vox Sanguinis|January 1, 1987
Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testingJ G Huisman, I N Winkel, P N Lelie, et al.
The Journal of Clinical Investigation|April 1, 1997
Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphomaM J Kersten, M R Klein, A M Holwerda, et al.
European Journal of Immunology|June 1, 1984
Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity)F Miedema, P A Tetteroo, W G Hesselink, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Normal telomere lengths in naive and memory CD4+ T cells in HIV type 1 infection: a mathematical interpretationK C Wolthers, A J Noest, S A Otto, et al.
Drug and Alcohol Dependence|April 27, 1999
New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug usersA Krol, C Flynn, D Vlahov, et al.
Clinical and Experimental Immunology|February 1, 1986
An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subsetV E Moss, F Miedema, E Matutes, et al.
Clinical and Experimental Immunology|August 1, 1985
T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneousF Miedema, F G Terpstra, J W Smit, et al.
Blood|October 15, 1990
Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudineH Schuitemaker, N A Kootstra, M H van Oers, et al.
Pageof 18